Africa’s largest drug maker Aspen Pharmacare is partnering with Danish healthcare firm Novo Nordisk to establish SA’s first production of human insulin. This could have a significant impact on healthcare in South Africa and the rest of Africa, as it would make human insulin more accessible and affordable.
Read the full article on Reuters.